Tags: tikun europe

Korinthos, 26/01/2023: . TikunOlam Europe, the pioneer pharmaceutical industry in the research, development and production of medical cannabis products in Greece, inaugurated the first and most innovative medical cannabis production unit in Europe in Examilia, Korinthos. The inauguration ceremony took place in the presence of the Minister of Development and Investments, Adonis Georgiadis, . the Deputy Minister of Research and Technology Christos Dimas and Deputy Minister for Planning and the Urban Environment Nikolaos Tagaras, the SYRIZA MP of Korinthos Georgios Psychogios, as well as other representatives of the political leadership, the local government, the scientific and business world and the media.

The TikunOlam Europe production unit is located in a privately owned area of 56,000 square meters in Korinthos, a total investment that exceeded 40 million euros. A vertically integrated production process, with a R&D department and state-of-the-art facilities and with cutting-age equipment. The site has three distinct units: the greenhouse cultivation unit, the primary processing unit and the production and packaging unit for finished medical cannabis products.

During the inauguration ceremony κ. Mr. Nikos Beis, CEO of TikunOlam Europe δstated: "Today, after 5 years of demanding and collective work, we are here to inaugurate the largest and most modern medical cannabis production unit, both in Greece and Europe and one of the largest units in the world. With this investment and the strategic partnerships we have entered into, Greece can now play a leading role in the medical cannabis market. This market is under development at an international level and at the same time is growing rapidly. We warmly thank all the political leaders who in recent years believed in the prospects of this market, contributing to the completion of a project that will primarily benefit Greek patients. As a company we are committed to producing high-quality products ensuring that patients around the world have access to safe and effective pharmaceuticals."

The Minister of Development and Investments, Mr. Adonis Georgiadis,after thanking all the executives of the Ministry of Development for the hard work they have done regarding the investments in medical cannabis, stressed: "Today is a historic day not only for Europe and the investment in Korinthos, but because today we pave the way for something that did not exist in Greece. A way to provide Greek patients with pharmaceutical cannabis products. But also a way for a product that we will be able to export throughout Europe, because this unit has the ability to make huge exports to all the major countries of Europe and so Greece will play a leading role in the coming years, spearheaded by this factory and the other factories that will come and work on what is called medical cannabis."

Moreover, the Deputy Minister of Research and Technology Christos Dimas σημείωσε: «An important day today for Korinthos, for Greece but especially for those patients who will benefit from the healing properties of medical cannabis. TikunOlam Europe 's investment is knowledge-intensive and has already created new, quality and well-paid jobs in our country."

During his speech Deputy Minister for Planning and the Urban Environment Nikolaos Tagaras said: "It is a special day for Korinthos because such a large pharmaceutical company has chosen to make this great investment in our country that creates many job opportunities for the local community. The political community is here with responsibility, next to the investors who choose and support Greece. For all of us, it is a national bet to pave the way for more innovative investments and we win it every day all together."

Speaking about the investment the SYRIZA MP of Korinthos Georgios Psychogiosconveying the message of the President of SYRIZA-PROGRESSIVE ALLIANCE Alexis Tsipras, he said characteristically: "I want to express my congratulations to the company for an innovative and pioneer project both for Korinthos, but also for the country, which came to life on the basis of the interests of local communities, maintaining the standards of Europe. I would like to point out that despite the fact that when this framework was made it was reprehensible by many, I am glad that we are now here to monitor the development of medical cannabis for both investors and patients who will now be able to access these medicines."

At the same time, in the context of the event, Mr. Nikos Karanikas said that an innovative idea becomes a reality with the inauguration of this unit, congratulating the entire team of TikunOlam Europe for the implementation of a demanding project, emphasizing that "ttoday we are here having overcome all obstacles and I could not feel more joy".

With the inauguration of this unit, our country acquires a high level of know-how that will help Greek and European patients to come closer to safe and effective treatments of recognized value.

The medical cannabis market 

Based on data on the latest European and global market trends for the industry, there has been an increase in the creation of units for the cultivation and processing of medicinal cannabis for commercial purposes in many European countries. However, Canada retains the lead as the largest exporter in Europe, but this is changing as more and more countries around the world begin their exports while at the same time Canadian producers shift the crop to Europe. In at least 15 European countries there are units for the cultivation and processing of medicinal cannabis for commercial purposes.  

In Europe, medicinal cannabis remains linked to the existing healthcare system, with treatment programmes strictly controlled by regulators as well as the licensing process done by state bodies. In particular, pilot projects on medicinal cannabis are progressing across the continent of Europe. Notably, the German medical cannabis market continues to grow steadily, with a 43% increase in cannabis sales in pharmacies at the end of 2021, with most of the growth coming from products sold to patients with private prescriptions. Medicinal cannabis products in Germany must have an EU-GMP certification, which adheres to high standards for the production and testing of medicines. More time is needed to build up production capacities at EU-GMP level than for non-certified treatment plants. 

In Greece, licenses are still at an early stage, although the first companies have already made their appearance by investing dynamically in the field with the creation of factories for the cultivation and processing of medicinal cannabis. 

As far as CBD products are becoming increasingly legalized, as of February 2022, the European Commission has registered at least 12 valid applications for CBD as novel foods, while the trend for approval of new applications is expected to continue in the very near future. In Greece, in June 2022, the relevant JMD (1/6/2022  
- 2712) was published, in which the terms and conditions of the legal production, placing on the market and marketing of dietary supplements containing Hemp of the species Cannabis Sativa L, i.e. CBD, are communicated. Until now, CBD products have been distributed exclusively through CBD stores or other hemp products. This special distribution has not so far contributed to the reliability and effectiveness of the category, even if the special stores give weight to cannabis products. Almost all developed European and not only countries (UK, Canada, Israel, etc.) currently have at the disposal of their patients the "tool" of medicinal cannabis for significantly improved quality of life. 

Regarding TIKUN

TIKUN Olam is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN Olam's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide. Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.  

About TikunOlam Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area in Corinth,2 in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with hi-tech equipment.

TIKUN Olam Europe’s activity is fully aligned with the Greek legislation provisions for the cultivation and processing of cannabis, aiming at the creation of pharmaceutical formulations that will be produced in a GMP environment and by applying strict control standards and procedures which ensure high quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real-World Data (RWD).

In addition, TIKUN Europe has been on the market since the beginning of 2022 and the TIKUN CBD product line produced in a certified factory in France, based on innovative formulas developed by its R&D division. The TIKUN CBD series acts on the annoyances of everyday life, while at the same time benefiting the entire human body. In other words, it ensures homeostasis, providing holistic, natural balance.

Media info

V+O Communication, Nasia Bourni - Tel. Contact 210 72 49 000 / +30 6936775484 - Email nb@vando.gr

Related: u18 football teams in london, when regulations seem contradictory or unclear, the oig issues, why is it called half tribe of manasseh, northwestern lehigh school district jobs, wyndham council ceo salary, virginia tech lee hall floor plan, nieto funeral home laredo tx obituaries, thank you note to hairdresser for funeral, the cottages at tucson shuttle, travis burns, md, what caused divisions in the corinthian church, eliane tile distributors, denaturation of egg white protein by acid, university of washington general surgery current residents, are arthur kennedy and george kennedy brothers,Related: president nelson vaccine statement, tredegar funeral notices, mvp health care plan type mvpm, cif baseball rankings 2022, most badass jobs in the world, what does randy name mean, did neil build a hotel in mccarthy, alaska, breast reduction photos at one week post op, pasrr level 1 screening tool, mazda vehicle tracking system, cave junction police blotter, fatal accident 95 north today, how powerful is enchantress marvel, pizzly bear aggression, logan sargeant father,Related: who does darez diggs play for, solana nft profit tracker, under suspicion ending, did etta place have a child, linguistic mode of teaching grammar, capricorn pisces soulmate, lake mohave water level, klm economy class food menu, fop lodge 7 retro calculator, growing up with strict mexican parents, carmax car transfer experience, is honey healthier than golden syrup, zoe bray cotton net worth, chris mcalister net worth, data hk siang,Related: best freshman dorms at university of tampa, esxi restart nfs services, zepto apps product personalizer, i love kickboxing cancellation fee, the kingston clan birth defects, strava profile picture dimensions, the compromise of 1850 postpones a crisis answer key, alex danson married, meg alexander husband, memory lane drive in concessions, private sushi chef fort lauderdale, ang kalupi ni benjamin pascual, mary berry chilli con carne, dave ramsey corporate office, happy birthday singing cards,Related: shady haven rv park payson, az, david senak obituary, george strait concert 2022, traxx bluetooth headphones pairing, where is safavieh furniture made, hallmark dreambook 2022, nyu journalism master’s acceptance rate, ohio softball tournaments 2022, ed sheeran support act 2022 manchester, louisiana court case search by name, julia duffy and peter scolari, underground by babezcanwrite pdf, italian old fashioned names, uncle passed away message to boss, commercial listing agreement form,Related: papa fear gaming plush, diction practice test, chris chelios career earnings, news and record greensboro, nc obituaries, pellet hopper conversion kit, strawberry daiquiri with everclear, stephen sandoval colorado, jackie giacalone net worth, what type of social media is stumbleupon, king 5 investigative reporters, mobile pet grooming new orleans, tufting workshop bay area, burkesville, ky mugshots, landfill convenience center, nigel and cherina wilson,Related: wood stove for sale craigslist nc, questionnaire on impact of social media on youth, how much liquid copper fungicide per gallon, discord rules bot, body language sitting positions, laporte county jail, shih tzu skin color changes, aja liner notes, mcps resources benchmark universe, club car speed sensor bypass, soul contract decoded calculator, florida on a tankful book, alpherior keys hayabusa manual, lane cedar chest patent numbers, james jannard wife,Related: mermaid tail succulent australia, samsung washer debris filter stuck, canik tp9sf trigger replacement, verado power steering pump troubleshooting, bren school acceptance rate, copper vs steel bbs, snap ring tool, thornless marionberry plants for sale, mdes investigation department, right chicken louie origin, picrew boyfriend maker, rough river lake fishing, franciscanalliance org make payments, skeletal juggernaut 5e, colt saa serial numbers 2nd generation,Related: open position tracking template, how to renew belarus passport in usa, fun teenage things to do in wichita, ks, vcu cary street gym guest policy, snake and apple unblocked, oakland oregon transfer station hours, solangelo fanfiction hogwarts, why would i get mail from the state controller, arthur john beckinsale, cessna 182 extended range fuel tanks, july 2, 1955 when pan am flight 914, unsolved murders in spartanburg, sc, sidearm stroke in badminton, fnaf world simulator clock locations, how silicon is made from sand,Related: berwick football whlm, alinta energy interview, funeral homes in marianna, arkansas, melody cristea age, nginx location with parameters, mobile homes for rent in edwardsville, ks, frances tiafoe wife cancer, elmira heights school district staff directory, navy officer promotion oath, zio’s italian nachos recipe, division 2 best solo build 2022, what to wear in miami in february 2021, iniu portable charger won’t charge, sherri papini still married, which of the following is true of export agents,Related: hubitat vs smartthings vs home assistant, how to get a kennel license in arkansas, shooting in lilburn, ga today, how to change blinking cursor to normal in eclipse, marquette high school football coach, raymond parks and rosa parks wedding, spokane police breaking news, travis clark softball, control remoto liberty pr, becky lynch and seth rollins wedding video, turnaround effect of prior period misstatements examples, texas rule of civil procedure 99, adam arnold crawley, lvndmark settings 2021, igloo dining raleigh nc,Related: mission us: prisoner in my homeland, persimmon balerno house, basic safe harbor match formula excel, hotels near 1045 19th st, virginia beach, va 23451, southcoast property transfers 2021, broken screw after spinal fusion symptoms, springer nature editor salary, what was mama odie trying to tell tiana, dr shoki north vancouver, difference between prose, poetry and drama, los angeles county department of mental health service area map, hart plaza, detroit festival schedule, united methodist church pastor assignments, geneva high school marching band, 1994 cleveland browns coaching staff,Related: 2022 bowman chrome baseball release date, characters named david, how old is titus tero, difference between autocracy and democracy, privately owned houses for rent in winston salem, nc, mckinsey associate partner bonus, golf cart brands to avoid, down east wood ducks front office, where does the bush family vacation in florida, birthday party venues los angeles adults, albert woodfox compensation, condos for rent in riverview, fl, ziggy sawdust only fools and horses, criticism of lewis model, how to spot fake hempz lotion,Related: human remains edmund fitzgerald crewman body photo, neues flugabwehrsystem bundeswehr, danny 101st airborne division little rock, applebees honey balsamic vinaigrette recipe, mount mansfield union high school student death 2020, just a dash matty matheson michelle, david sobey net worth, narragansett times police beat, shawn levy related to eugene levy, how old is marlene harmon, sycuan industry mondays, how do nfl teams choose which uniform to wear, berryville, va newspaper obituaries, 5 importance of transportation in nigeria, victory brinker biography,Related: lao gan ma cancer, what could have been a possible solution to the soviet oil drilling problem, crowded house support act 2022, new businesses coming to derby, ks 2021, bts reaction to you being traumatized, designer city food for diamonds, euphoria font copy and paste, how to program color buttons on lg remote, do you have to use verifly with british airways, mike shannon first wife, why did laura hayes leave in the cut tv show, things we never got over lucy score summary, does tequila rose need to be refrigerated, baptist international outreach, quintin demps wife,Related: bingham high school student death, santos vs palmeiras confrontos, sadlier vocabulary workshop level green, saddleworth moor car park, south asian food distributors, the gifted fanfiction lauren and john, walker funeral home shawnee, ok, john carr replacement window handles, giant skeletons found in kentucky, philadelphia phillies fan mail address, dark feminine energy affirmations, pool sand calculator, recent deaths in herington, ks, cbc interpretation calculator, coolidge house 307 huntington ave,Related: harley davidson payment grace period, where is sheriff ricky edwards now, miami regional university nurse practitioner program, is unfinity legal in commander, woodstock photos for brave eyes only, best primary care doctors birmingham, al, used cattle squeeze chutes for sale in texas, beau flynn net worth, moraine fishing report, lipedema specialist arizona, residential mental health facilities for adults, how much powdered milk to make 1 pint, is mike grady actor married, shark teeth dauphin island, when a guy asks how you’re feeling,Related: kareem biggs” burke net worth 2021, anthony arillotta family, neptune society refund policy, why did mr french wear a bandage on his right hand, australian netball salary, guest house for rent woodland hills craigslist, neverwinter nights enhanced edition item list, hmrc certificate of residence contact number, heather salt lake city ex husband sick, dorothy jeter obituary, fruit of the loom alternative, rex meeker anesthesiologist, obituaries griffin, ga 2022, richest kid in cameroon, glendale jeep commercials,Related: adam miller cornerstone wife, , hitman 2 isle of sgail hitching a ride, atlantis bahamas bars, lse finance job market candidates, port arthur massacre photos, sun journal new bern, nc obituaries, dr omar suleiman wife esraa, what happened to mike from the mixing bowl, slay the spire console commands, how to become a health inspector in texas, jefferson parish arrests march 2021, lindsay bronson height, brianna chickenfry cancelled, connaught rangers list of names,Related: little league world series 2022 regionals, philip roenick detroit red wings, blood covenant between man and woman, how many actresses played rachel greene on er, john and natalie storage hunters net worth, chocolate hazelnut torte women’s weekly, geauga county police scanner, easyjet chatbot, waffle house grilled chicken recipe, day trips from santa margherita ligure to cinque terre, explain how to overcome barriers in partnership working, middletown de shooting 2021, azalea festival 2022 schedule, wheatley golf club pro shop, northampton car accident today,
Κόρινθος, 26/01/2023: Η TikunOlam Europe, η πρωτοπόρος φαρμακοβιομηχανία στην έρευνα, ανάπτυξη και παραγωγή προϊόντων φαρμακευτικής κάνναβης στην Ελλάδα, εγκαινίασε την πρώτη και...

Athens, 15 November 2022 . TIKUN Europe, the leading pharmaceutical company in research, development and production of medical cannabis products in Greece, and the Greek pharmaceutical group Lavipharm, are entering into a strategic partnership for the distribution of Tikun’s new products, which are anticipated to be launched in the Greek market in 2023.

Tikun’s new product lines concern, both the finished medical cannabis products that will be produced exclusively at its facility in Greece, and the new specialized line of cannabidiol (CBD) food supplements to be produced at a certified production facility in France. As part of the agreement, Lavipharm will assume the commercial distribution of Tikun’s products in the Greek market. The duration of the contract is 5 years, with an option to further renew.

The market for medical cannabis in Europe is growing rapidly, reflecting the need of both the medical community and patients. In the Greek market, the agreement with Tikun Europe further strengthens Lavipharm’s portfolio in the therapeutic categories of focus, such as Oncology, Chronic Pain and the Central Nervous System.

. Mr. Nikos Beis, CEO Tikun Europe,e, noted that“The Tikun Europe team is very pleased to welcome this strategic alliance with Lavipharm, a historic and innovative Greek pharmaceutical group, representing another significant move for us. The two companies are joining forces – starting with production at Tikun’s plant and then with commercialisation through the Lavipharm channels – to give Greek patients access to medication that they have not had until today. This new agreement serves our strategic decision to create alliances with major pharmaceutical partners, Lavipharm and Pharmaserve Hellas, with the aim to make available high quality medical cannabis products that are effective in supporting the treatment of patients with severe conditions, as well as a new line of CBD food supplements for improving consumers overall well-being.”

. Mr. Telemaque Lavidas, Executive Board Member of Lavipharm, commentedΕίμαστε ενθουσιασμένοι από τη στρατηγική συμμαχία της Lavipharm με την TIKUN Europe, η οποία διαθέτει στην Ελλάδα ένα υπερσύγχρονο φαρμακευτικό εργοστάσιο σύμφωνα με τα αυστηρότερα πρότυπα παγκοσμίως. Στόχος της συνεργασίας μας αποτελεί η πρόσβαση ασθενών, που μέχρι σήμερα δεν είχαν τη δυνατότητα, σε αγωγή  φαρμακευτικής κάνναβης για την αντιμετώπιση ενός ευρέος φάσματος παθήσεων, καθώς και η βελτίωση της ποιότητας ζωής των καταναλωτών με τα συμπληρώματα διατροφής CBD. Παράλληλα, διευρύνουμε το χαρτοφυλάκιό μας στις κατηγορίες που ήδη δραστηριοποιούμαστε με αξιόπιστα, αποτελεσματικά και ασφαλή φαρμακευτικά προϊόντα, παραμένοντας πιστοί στην στρατηγική επικέντρωσης που ακολουθούμε». Commenting further, Mr. Lavidas added that“Lavipharm’s new agreement and the recent collaboration between Tikun Europe and a respectable counterpart such as Pharmaserve Hellas points to the need for major companies with a significant footprint in the Greek pharmaceutical market to ensure that healthcare professionals (doctors and pharmacists) have access to scientifically documented information for the benefit of patients.”

Regarding TIKUN

TIKUN is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide.Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.

About TIKUN Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area2 in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with hi-tech equipment.

TIKUN Europe’s activity is fully aligned with the Greek legislation provisions for the cultivation and processing of cannabis, aiming at the creation of pharmaceutical formulations that will be produced in a GMP environment and by applying strict control standards and procedures which ensure high quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real Clinical Practice Data (RWD).

In addition, TIKUN Europe has been on the market since the beginning of 2022 with the TIKUN CBD product line produced in a certified production facility in France, based on innovative formulas developed by its R&D division. The Tikun CBD food supplement range includes 5 products and targets everyday discomforts while also benefitting the whole body by providing holistic, natural balance.

About Lavipharm

Lavipharm has been active in the pharmaceutical field since 1911, always aiming to support the vital work of doctors and pharmacists by providing reliable therapy options. Its portfolio includes innovative and effective pharmaceutical products that meet patients’ daily needs. With over a century of history, it is today an integrated pharmaceutical group engaged in research, development, production, marketing and distribution in Greece, with strong international activity. Since 1995, the company has been listed on the Athens Stock Exchange (ASE: LAVI).

Media info

V+O Communication, Nasia Bourni - Tel. Contact 210 72 49 000 / +30 6936775484 - Email nb@vando.gr

Lavipharm, Katerina Fragioudakis - Tel.+30 210 6691 106 – Email: communcations@lavipharm.com

Αθήνα, 15/11/2022: Σε στρατηγική συνεργασία προχωρούν η TIKUN Europe, η πρωτοπόρος φαρμακοβιομηχανία στην έρευνα, ανάπτυξη και παραγωγή προϊόντων φαρμακευτικής κάνναβης στην Ελλάδα,...

Αθήνα, 19/10/2022: . TIKUN Europe, η πρωτοπόρος φαρμακοβιομηχανία στην έρευνα, ανάπτυξη και παραγωγή προϊόντων φαρμακευτικής κάνναβης στην Ελλάδα, ενώνει τις δυνάμεις της δημιουργώντας μια στρατηγική συμμαχία με την ΦΑΡΜΑΣΕΡΒ ΕΛΛΑΣ, η οποία θα είναι ο αποκλειστικός αντιπρόσωπος του brand name TIKUNCBD στην Ελλάδα.

Το πλαίσιο της συνεργασίας θα αφορά αρχικά στην ενημέρωση, προώθηση και διανομή της σειράς συμπληρωμάτων διατροφής TIKUN CBD στα φαρμακεία, καθώς και τις φαρμακαποθήκες, ώστε οι Έλληνες καταναλωτές και επιστήμονες Υγείας να έχουν πρόσβαση στα προϊόντα TIKUNCBD.

Στόχος των δύο εταιριών είναι να βρεθούν δίπλα στην επιστημονική κοινότητα και στους Έλληνες καταναλωτές, προκειμένου να ενημερωθούν πλήρως και ταχύτατα αναφορικά με την προϊοντική σειρά TIKUN CBD και για τα οφέλη που προσφέρει στους καταναλωτές και στους ασθενείς μέσω των επαγγελματιών Υγείας.

Η σειρά TIKUN CBD περιλαμβάνει 5 προϊόντα και δρα επικεντρωμένα στην βελτίωση της καθημερινότητας ενώ συγχρόνως ωφελεί ολόκληρο τον οργανισμό παρέχοντας ολιστική, φυσική ισορροπία. Τα συγκεκριμένα προϊόντα παράγονται σε πιστοποιημένο εργοστάσιο στη Γαλλία, με βάση καινοτόμες φόρμουλες που έχει αναπτύξει το R&D τμήμα της εταιρείας στην Ελλάδα και προσφέρουν φυσική ολιστική ισορροπία, συμβάλλοντας μοναδικά στην ενίσχυση της ευεξίας του ανθρώπινου οργανισμού.

. Νίκος Μπέης, CEO της TIKUN Europe, noted thatΕίναι μεγάλη χαρά για την ομάδα της TIKUNEurope η κομβική συνεργασία, που αποτελεί ορόσημο, με την ΦΑΡΜΑΣΕΡΒ που θα μας κάνει συνοδοιπόρους στην ενημέρωση και προώθηση της σειράς TIKUN CBD. Πιστεύουμε πολύ σε αυτή την ένωση δυνάμεων καθώς έχουμε ένα καινοτόμο και πιστοποιημένο προϊόν και σε συνδυασμό με την εμπειρία των ανθρώπων και του δικτύου της ΦΑΡΜΑΣΕΡΒ, θα καταφέρουμε να είναι ευκολότερα διαθέσιμο και προσβάσιμο σε καταναλωτές και επαγγελματίες Υγείας μέσω του Ελληνικού Φαρμακείου».

. Σπύρος Φιλιώτης, Αντιπρόεδρος της ΦΑΡΜΑΣΕΡΒ ΕΛΛΑΣ, commentedΕίμαστε ενθουσιασμένοι για την ευκαιρία να συνεργαστούμε με μια εταιρία πρωτοπόρο στο χώρο της όπως η TIKUN. Πιστεύουμε πως τα άριστα προϊόντα TIKUNCBD θα φέρουν μια σημαντική αλλαγή στην συνείδηση των επιστημόνων Υγείας και των καταναλωτών για την χρήση προϊόντων CBD. Λόγω της εξαιρετικής ποιότητας, της μεγάλης εταιρίας που εγγυάται την ποιότητα και την επιστήμη που τα υποστηρίζει, είμαστε σίγουροι πως τα TIKUNCBD θα συμβάλλουν στην ενίσχυση της ευεξίας των καταναλωτών στην Ελλάδα»

Regarding TIKUN

TIKUN is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide. Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.

About TIKUN Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with equipment of latest technology.

TIKUN Europe’s activity is fully aligned with the Greek legislation provisions for the cultivation and processing of cannabis, aiming at the creation of pharmaceutical formulations that will be produced in a EU-GMP environment and by applying strict control standards and procedures which ensure high quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real-World Data (RWD).

Επιπρόσθετα, η εταιρία TIKUN Europe διαθέτει στην αγορά από τις αρχές του 2022 και την προϊοντική σειρά TIKUN CBD που παράγεται σε πιστοποιημένο εργοστάσιο στη Γαλλία, βασισμένη σε καινοτόμες φόρμουλες που έχει αναπτύξει το R&D τμήμα της. Η TIKUN CBD σειρά δρα επικεντρωμένα στις ενοχλήσεις της καθημερινότητας, ενώ συγχρόνως ωφελεί ολόκληρο τον ανθρώπινο οργανισμό. Εξασφαλίζει δηλαδή την ομοιόσταση,  παρέχοντας ολιστική, φυσική ισορροπία.

Για την ΦΑΡΜΑΣΕΡΒ ΕΛΛΑΣ

Η Φαρμασέρβ ιδρύθηκε το 1984 και διανύει την τέταρτη δεκαετία δραστηριότητας στην ανθρώπινη υγεία στην Ελλάδα. Η Φαρμασέρβ με πολλά χρόνια παρουσίας στον κλάδο των φαρμάκων και των παραφαρμακευτικών προϊόντων ενισχύει σταθερά την πορεία της και βρίσκεται μεταξύ των 10 πρώτων φαρμακευτικών εταιρειών που δραστηριοποιούνται στην Ελληνική αγορά.

Ως πρωτοπόρος εταιρεία στο χώρο της ανθρώπινης υγείας η Φαρμασέρβ επενδύει στην άριστη τεχνογνωσία και ποιότητα, στην κλινική έρευνα, σε υπερσύγχρονο κέντρο διανομής και στην επιστημονική ενημέρωση των επαγγελματιών υγείας.

Η Φαρμασέρβ επενδύει στις συνεργασίες της με διαπρεπείς επιστημονικούς οργανισμούς και σημαντικές συνεργασίες με διεθνώς καταξιωμένες εταιρείες με ποιοτικά φάρμακα, παραφαρμακευτικά και προϊόντα ανθρώπινης περιποίησης και υγείας.

Media info
V+O Communication, Nasia Bourni - Tel. Contact 210 72 49 000 / 6936775484 - Email nb@vando.gr nb@vando.gr

Αθήνα, 19/10/2022: Η TIKUN Europe, η πρωτοπόρος φαρμακοβιομηχανία στην έρευνα, ανάπτυξη και παραγωγή προϊόντων φαρμακευτικής κάνναβης στην Ελλάδα, ενώνει τις δυνάμεις της...

Athens, 28/07/2022 TIKUN Europethe largest pharmaceutical company in the medical cannabis industry in Europe, pioneer in the research, development and production of medicinal cannabis products worldwide, welcomed the first mother plants from Israel, for the purpose of starting the cultivation in the company’s facility at Korinthos. The transportation of the mother plants took place on Friday, July 22nd and was carried out by Skyserv Ground Handling Services at Athens International Airport, Eleftherios Venizelos, in the presence of company’s executives.

The shipment of the plants was made in specially designed containers under controlled environment ensuring the best possible conditions throughout the transportation from Israel to their final destination. The plants, after the clearance from the competent authorities, were immediately transferred to the company’s production unit at Korinthos, in order to initiate the transplantation process. The company aims in the immediate initiation of cultivation in the vertically integrated greenhouse unit, with an area of 21,000 m2 and an annual production capacity, reaching in full growth, the quantity of 10 tons of dry flower. The plants received will be used for propagation under strict protocols that will ensure the preservation of the unique characteristics of the mother plants to the future generations. The facility is expected to reach its full capacity levels gradually in the near future, to deliver a wide variety of finished medical cannabis dosage forms.

TIKUN Europe’s greenhouse and production units are designed to comply with the GACP / EU-GMP standards, which ensure high quality and safety complying with the national legislation for the cultivation and processing of medical cannabis. TIKUN Europe holds all the necessary licenses and certifications in order for its operation to be carried out with absolute responsibility and respect for the environment and the local community.

The Nikos Beis CEO ofTIKUN Europe said: “We welcome the first mother plants to our facilities in Greece. Their arrival marks the beginning of production at the factory in Korinthos, which takes us one step closer to the realization of our commitment. Our factory, being the largest pharmaceutical facility in its industry in Europe, is committed to creating innovative, high-quality medical cannabis products. A new era is beginning for our country with the operation of our Tikun Europe facility, paving the way for Greece to become one of the main players in the field of production and export of medical cannabis products”.

The Dimitris Giannopoulos, COO & Vice President of the Board of TIKUN Europe, stated: “After completing the construction of our production facility in Korinthos, today signifies another important milestone, that brings us one step closer to the beginning of cultivation of medical cannabis plants in the country. The main challenge and opportunity now become the development and production of a complete portfolio of high quality finished medical cannabis products to meet the needs of patients in Greece and in Europe”.

. Martha Georgila, Commercial Director of Skyserv Ground Handling Services, stated: "We are very happy that TIKUN Europe trusted Skyserv to implement the first transport of mother plants in Greece. Following all transportation protocols for that type of merchandises, along with the specific storage conditions that were required during their stay at the airport area, we managed to keep them intact until their departure to the company's factory in Korinthos".

Regarding TIKUN

TIKUN is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide. Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.

About TIKUN Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with equipment of latest technology.

TIKUN Europe’s activity is fully aligned with the Greek legislation provisions for the cultivation and processing of cannabis, aiming at the creation of pharmaceutical formulations that will be produced in a EU-GMP environment and by applying strict control standards and procedures which ensure high quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real-World Data (RWD).

At the beginning of 2022, TIKUN Europe will launch its CBD product line, which is produced in a certified factory in France, based on innovative formulas developed by its R&D division. The TIKUN CBD series helps with the everyday life annoyances, while at the same time benefits the entire human body. In other words, it ensures homeostasis, providing holistic, natural balance.

Media info
V+O Communication, Nasia Bourni - Tel. Contact 210 72 49 000 / 6936775484 - Email nb@vando.gr nb@vando.gr

Αθήνα, 25/07/2022: Η TIKUN Europe, η μεγαλύτερη φαρμακοβιομηχανία της Ευρώπης στον κλάδο της φαρμακευτικής κάνναβης, πρωτοπόρος στην έρευνα, ανάπτυξη και παραγωγή προϊόντων...

Athens, 06/06/2021: . TIKUN Europe, the largest pharmaceutical company in the medical cannabis industry in Europe, has received a license to start the operations on its factory. The production process of the final medical cannabis products is expected in the near future.

TIKUN Europe’s factory is located in a privately owned area of 56,000 sq. m. in Corinth and is an investment of more than 30 million euros. The production facility is fully vertically integrated, having a R&D department and high-tech equipment. Tikun Europe’s factory has three distinct units: the greenhouse cultivation area, the post-harvest processing area, and the area designated for the production and packaging of finished medical cannabis products.

Also, TIKUN Europe’s factory, complies with the GACP / EU-GMP standards of the European Union and the domestic legislation for the cultivation and processing of medical cannabis, while its operation will be carried out with absolute responsibility and respect for the environment and the local community.

The new production unit was visited by the Minister of Development and Investments, Adonis Georgiadis, on Friday, June 3rd. The Minister's visit took place at a pivotal/crucial moment for the Company, following the legislation on medical cannabis and his first tour of the factory that had taken place 2 years ago. The Minister confirmed that the Government's commitment to investments has been implemented, with the plant launching the production process starting July.

The Nikos Beis CEO of TIKUN Europe said: "It was a great pleasure to welcome the operating license of our production unit, the construction of which was recently completed. The operation of the plant will start very soon, bringing us one step closer to the realization of our vision: to meet the ever-increasing demand of Greece and Europe for high quality medical cannabis products. Our factory is the largest pharmaceutical company in the specific industry in Europe and exploits the potential of our country to play a leading role in the global market for medical cannabis."

Regarding TIKUN

TIKUN is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide. Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.

About TIKUN Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with equipment of latest technology.

TIKUN Europe’s activity is fully aligned with the GACP/GMP principles and the provisions of Greek legislation for the cultivation and processing of medical cannabis, ensuring high product quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real-World Data (RWD). 

At the beginning of 2022, TIKUN Europe will launch its CBD product line, which is produced in a certified factory in France, based on innovative formulas developed by its R&D division. The TIKUN CBD series helps with the everyday life annoyances, while at the same time benefits the entire human body. In other words, it ensures homeostasis, providing holistic, natural balance.

Media Enquiries

V+O Communication, Nasia Bourni - Tel. Contact 210 72 49 000 / 6936775484 - Email nb@vando.gr nb@vando.gr

Αθήνα, 06/06/2021: Η TIKUN Europe, η μεγαλύτερη φαρμακοβιομηχανία στον κλάδο της Φαρμακευτικής Κάνναβης στην Ευρώπη, έλαβε άδεια για την έναρξη λειτουργίας του...

. TIKUN Europe, 1η εταιρεία φαρμακευτική κάνναβης στην Ελλάδα, έδωσε το παρών στη 12η Health Expo Athens, την εκδήλωση-θεσμό για τον ευρύτερο χώρο της Υγείας, η οποία πραγματοποιήθηκε δια ζώσης στις 21 και 22 Μαΐου στο Κέντρο Πολιτισμού «Ελληνικός Κόσμος» και στις 23 Μαΐου μέσω διαδικτυακής μετάδοσης.Στο περίπτερο της εταιρείας, οι επισκέπτες της έκθεσης είχαν την ευκαιρία να ενημερωθούν από τους εκπροσώπους της TIKUN Europe αναφορικά με την επιχειρηματική της δραστηριότητα, καθώς και τη νέα σειρά συμπληρωμάτων διατροφής TIKUN CBD, η οποία λανσαρίστηκε πρόσφατα στην ελληνική αγορά με το κοινό να δείχνει υψηλό ενδιαφέρον. Στην Ελλάδα είναι διαθέσιμα 5 προϊόντα της σειράς TIKUN CBD, τα οποία παράγονται σε πιστοποιημένο εργοστάσιο της Γαλλίας, με βάση καινοτόμες φόρμουλες που έχει αναπτύξει το R&D τμήμα της εταιρείας στην Ελλάδα και προσφέρουν ολιστική, φυσική ισορροπία. Η αποκλειστική διάθεση όλων των προϊόντων γίνεται μέσω του καναλιού του φαρμακείου.

Όσον αφορά στην επιχειρηματική της δραστηριότητα, η εταιρεία ενημέρωσε τους ενδιαφερόμενους σχετικά με την αποστολή και το όραμα της, η οποία προσδοκά να ανταποκριθεί στις διαρκώς αυξανόμενες ανάγκες της εγχώριας και ευρωπαϊκής αγοράς για σκευάσματα φαρμακευτικής κάνναβης και προϊόντα CBD.

H Marketing Manager της TIKUN Europe, Ντορέτα Δαρμανή, stated: «Είναι μεγάλη χαρά για εμάς η συμμετοχή σε μια τόσο σημαντική διοργάνωση, η οποία αποτελεί σημείο συνάντησης κορυφαίων εταιρειών και επαγγελματιών από τον χώρο της Υγείας. Στόχος μας είναι να συμβάλουμε στην έγκυρη ενημέρωση των Φαρμακοποιών, τόσο για τις εξελίξεις στον κλάδο της φαρμακευτικής κάνναβης, όσο και για το λανσάρισμα της νέας σειράς Tikun Live with CBD στο Ελληνικό Φαρμακείο, που εξασφαλίζει ολιστική, φυσική ισορροπία.».

Regarding TIKUN

TIKUN is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide. Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.

About TIKUN Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with equipment of latest technology.

TIKUN Europe’s activity is fully aligned with the GACP/GMP principles and the provisions of Greek legislation for the cultivation and processing of medical cannabis, ensuring high product quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real-World Data (RWD). 

At the beginning of 2022, TIKUN Europe will launch its CBD product line, which is produced in a certified factory in France, based on innovative formulas developed by its R&D division. The TIKUN CBD series helps with the everyday life annoyances, while at the same time benefits the entire human body. In other words, it ensures homeostasis, providing holistic, natural balance.

Media Enquiries

V+O Communication, Νάσια Μπουρνή, Τηλ. Επικοινωνίας 2107249000/6936775484, Email nb@vando.gr

Αθήνα, 30/05/2022: Η εταιρεία συνεχίζει τη δυναμική παρουσία της σε σημαντικές εκθέσεις του κλάδου της Υγείας

Τι είναι όμως το CBD; Γιατί όλο και περισσότεροι καταναλωτές σήμερα το κάνουν μέρος της καθημερινότητάς τους και με ποιον τρόπο συνδέεται με την ισορροπημένη καθημερινότητα, την ευεξία, την αρμονία, την τόνωση και τον ποιοτικό ύπνο που θέλεις και χρειάζεται να απολαμβάνεις;

Αν παρακολουθείς και διαβάζεις συχνά για τις νέες τάσεις στον κόσμο της ευεξίας και της ομορφιάς, τότε πιθανότατα έχεις παρατηρήσει πως υπάρχει μία έννοια, ένα ακρωνύμιο που επανέρχεται ξανά και ξανά. Για την ακρίβεια, βρίσκεται στις πρώτες θέσεις της λίστας σε ό,τι αφορά στα must του κόσμου της σύγχρονης ευεξίας και έχει συνδεθεί έντονα με την ισορροπία στη ζωή μας και τη διασφάλιση του wellbeing μας. Ο λόγος, φυσικά, για το CBD! Ή αλλιώς κανναβιδιόλη!

Τι είναι όμως το CBD; Γιατί όλο και περισσότεροι καταναλωτές σήμερα το κάνουν μέρος της καθημερινότητάς τους και με ποιον τρόπο συνδέεται με την ισορροπημένη καθημερινότητα, την ευεξία, την αρμονία, την τόνωση και τον ποιοτικό ύπνο που θέλεις και χρειάζεται να απολαμβάνεις;

Σε μία καθημερινότητα που σε βρίσκει να «τρέχεις» όλη μέρα και να επιστρέφεις στο σπίτι, νιώθοντας άγχος και ατονία, το CBD μπορεί να αποτελέσει τη λύση που έψαχνες. Συνέχισε, λοιπόν, να διαβάσεις για να μάθεις τα πάντα για τη wellness πλευρά του CBD!

Ανακαλύπτοντας τα ευεργετικά οφέλη των προϊόντων CBD

Ας πάρουμε τα πράγματα από την αρχή, δηλαδή από το τι είναι το CBD. Πρόκειται, λοιπόν, για ένα από τα βασικά κανναβινοειδή, που χρησιμοποιούνται εδώ και χιλιάδες χρόνια με στόχο τη βελτίωση της ποιότητας ζωής.

«Και πώς θα με βοηθήσει;», θα μας ρωτήσεις. Αρκεί να σκεφτείς ότι η κατανάλωση προϊόντων CBD, συμβάλλει στη σωματική και ψυχική ευεξία, στην τόνωση και την ενεργητικότητα, στην καλύτερη διαχείριση του μυϊκού πόνου, στην αντιμετώπιση του άγχους και στην επαναφορά του οργανισμού σε ισορροπία, για να καταλάβεις γιατί όλο και περισσότεροι καταναλωτές στρέφονται σε αυτά σήμερα.

yoga woman on green park 2021 08 26 15 50 38 utc 1

Μεταξύ άλλων όμως, το CBD μπορεί επίσης να αναβαθμίσει πολύ και τον ύπνο σου και να σε βοηθήσει να κοιμάσαι καλύτερα και να αντιμετωπίσεις τις αϋπνίες ή άλλες διαταραχές ύπνου που σε ταλαιπωρούν. Και με τις διαταραχές ύπνου να έχουν εξελιχθεί σε «μάστιγα» στις μέρες μας και το φαινόμενο της αϋπνίας να ταλαιπωρεί περισσότερο τις γυναίκες – σύμφωνα με νέες έρευνες- το να μπορούμε να κοιμόμαστε καλύτερα, αποτελεί βασικό μας μέλημα!

Με λίγα λόγια, η κατανάλωση προϊόντων CBD μπορεί να συμβάλλει ολιστικά στην ενίσχυση της ευεξίας σου, στηρίζοντας την αρμονία και την ισορροπία ανάμεσα στη φυσική, νοητική και συναισθηματική σου κατάσταση και δίνοντάς σου την τόνωση που χρειάζεσαι, στο πλαίσιο ενός έντονου, απαιτητικού και συχνά στρεσογόνου τρόπου ζωής.

Πώς να βρεις και να επιλέξεις σωστά τα προϊόντα Live with CBD που χρειάζεσαι

Πώς όμως θα διαλέξουμε τα σωστά προϊόντα CBD από την πληθώρα των σχετικών προϊόντων που κυκλοφορούν στην αγορά; Αρκετοί καταναλωτές, παρότι θέλουν να δοκιμάσουν τις ευεργετικές ιδιότητες του CBD, αποθαρρύνονται από το γεγονός ότι αρκετά προϊόντα που κυκλοφορούν στην αγορά δεν εμπνέουν ασφάλεια, ούτε συνδέονται με κάποιο αξιόπιστο brand.

Γι’ αυτό σου προτείνουμε να επιλέξεις ένα CBD προϊόν, το οποίο φτάνει σε σένα με την αξιοπιστία που προσφέρει μία φαρμακευτική εταιρεία. Συγκεκριμένα, φρόντισε να αγοράσεις  ένα προϊόν που πωλείται αποκλειστικά στα φαρμακεία, ενώ καλό είναι να είσαι σίγουρη ότι το CBD προϊόν που θα πάρεις, έχει ελεγχθεί η ποιότητά του.

cbd oil against marijuana plant 2021 09 01 14 42 11 utc 1

Επίσης, πρέπει να πιστοποιείται στη συσκευασία ότι τα συστατικά που περιέχει είναι φυτικής προέλευσης και ότι δεν περιέχουν χημικές και επιβλαβείς ουσίες, καθώς και ότι το συγκεκριμένο προϊόν δεν προκαλεί αλλεργίες, ότι προέρχεται από πιστοποιημένες vegan Α’ ύλες και ότι περιέχει CBD ευρέως φάσματος, ώστε να έχει υψηλότερη φυσική αποτελεσματικότητα. Ακόμη, είναι σημαντικό να έχει στη συσκευασία του και φύλλο οδηγιών με αναλυτικές πληροφορίες σχετικά με τη σύστασή του και την ενδεδειγμένη δοσολογία. Ιδανικό θα ήταν η προϊοντική σειρά που θα επιλέξεις, να παρέχει εξειδικευμένες προτάσεις που στη σύνθεση τους περιέχουν και πρόσθετα φυτοκανναβινοειδη όπως το CBG και το CBN. Το CBD συνδυάζεται  αρμονικά με το CBG και έχει ενισχυμένη αποτελεσματικότητα στην αντιμετώπιση του μυϊκού πόνου. Ενώ ο αρμονικός συνδυασμός CBD με CBN  βοηθά όχι μόνο στην άμεση χαλάρωση πριν τον ύπνο αλλά επιπλέον εγγυάται ποιοτικό, χωρίς διαλείμματα ύπνο. Σε κάθε περίπτωση, τα καλά νέα είναι πως τα CBD προϊόντα πωλούνται ήδη στην ελληνική αγορά, ενώ παράγονται από βιομηχανική κάνναβη, για αυτό και δεν είναι εθιστικά δεν έχουν δράση ψυχοτρόπο και δεν έχουν παρενέργειες.

Αν αισθάνεσαι, λοιπόν, ότι έχεις ανάγκη να βρεις ξανά την ισορροπία στη ζωή σου, αν υποφέρεις από έντονο στρες, διαταραχές ύπνου ή σωματικούς πόνους και γενικά, αν έχεις ανάγκη από τόνωση, μπορείς να δοκιμάσεις και εσύ όσα μπορούν να σου προσφέρουν τα CBD προϊόντα. Όπως και να έχει, είναι σημαντικό να θυμάσαι ότι μπορεί να μην απαιτείται ιατρική συνταγή για τη χορήγησή τους, ωστόσο, η δοσολογία διαφέρει από άνθρωπο σε άνθρωπο, για αυτό καλό είναι να μελετήσεις καλά το φύλλο οδηγιών ή να συμβουλευτείς τον φαρμακοποιό σου, ώστε να σε κατευθύνει καταλλήλως.

TIKUN Europe, the first pharmaceutical company active in the field of medical cannabis in Greece, has completed the construction of its greenhouse cultivation unit, which is located at the region of ​​Corinth, in Peloponnese. The company will apply for the operations license by the end of March 2022. With an investment that is expected to exceed €40.000.000, TIKUN Europe has created a 56,000m2 state-of-the-art production site, with facilities and equipment of latest technology. The facility has three distinct units: the greenhouse cultivation area, the post-harvest processing area and the area designated for the production and packaging of finished medical cannabis products. 

The 21,000m2 greenhouse is the first unit designed to produce medical cannabis in Greece and the site where actual cultivation of medical cannabis plants will take place in the upcoming months. The plants will be used to create TIKUN Europe’s innovative and high-quality medical cannabis products. The facility has an annual production capacity of 10tons of dry flower that can be used for the production of various finished dosage forms. Plans include its possible expansion by 50%, with a subsequent production increase. 

Overall, TIKUN Europe’s greenhouse and manufacturing facility complies with EU GACP/GMP standards and local legislation for the cultivation and processing of medical cannabis.

All process steps are incorporated in the Quality System of the company, ensuring the high product quality and safety.

The company is in the process of obtaining all the necessary licenses and certifications and will operate with high responsibility and respect to the environment and the local community.

The cultivation operations are estimated to commence in April 2022. The GMP certification and the initiation of operations of the manufacturing facility is scheduled for June 2022.

TIKUN Europe is about to launch a complete range of CBD products; the TIKUN CBD range, a Holistic, Natural Balance offering, which is produced in a certified Factory in France.

Regarding TIKUN

TIKUN is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide. Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.

About TIKUN Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with equipment of latest technology.

TIKUN Europe’s activity is fully aligned with the GACP/GMP principles and the provisions of Greek legislation for the cultivation and processing of medical cannabis, ensuring high product quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real-World Data (RWD). 

At the beginning of 2022, TIKUN Europe will launch its CBD product line, which is produced in a certified factory in France, based on innovative formulas developed by its R&D division. The TIKUN CBD series helps with the everyday life annoyances, while at the same time benefits the entire human body. In other words, it ensures homeostasis, providing holistic, natural balance.

Media Enquiries

V+O Communication, Nasia Bourni - Tel. Contact 210 72 49 000 / 6936775484 - Email nb@vando.gr

Athens, 24/01/2022: Educational program for informing doctors & pharmacists on medicinal cannabis

Athens, 23.02.2022 TIKUN Europe, the first pharmaceutical company active in the field of medical cannabis, in Greece, announces the founding of its subsidiary company, TIKUN Europe Netherlands BV, which will be based in Amsterdam. 

The newly founded company will be responsible for the marketing,2 sale and distribution of TIKUN Europe’s CBD line in the European market.

The product line which will be launched initially in the Greek market this coming Spring, introduces new, innovative CBD products developed by the «Research and Development (R&D) Department» of TIKUN Europe. This R&D unit is based in Greece and has created original CBD product formulas, manufactured in a certified factory in France, under the most rigorous quality standards.

TIKUN Europe’s activity is fully aligned with the Greek legislation provisions for the cultivation and processing of medical cannabis, aiming at the creation of pharmaceutical formulations that are produced in a GMP environment, whilst applying strict control standards and procedures to ensure high quality and safety. TIKUN Europe Netherlands BV, which is not a pharmaceutical company, will be responsible for the CBD product line.

Regarding TIKUN

TIKUN is a pioneering company in the research, development, and production of medicinal cannabis products worldwide. Defining the market of medicinal cannabis in 2005, it began its activity in Israel and in the course of time expanded with production units in the USA, Canada, Australia, Asia (Israel) and Europe (based in Greece). With more than 15 years of clinical and laboratory studies and an extensive database of tens of thousands of patients worldwide, TIKUN's innovative pharmaceutical formulations are based on cannabis strains that have been awarded worldwide. Its medications offer support for serious conditions, such as Parkinson's disease, Crohn's disease, Autism, multiple sclerosis, epilepsy, side effects from chemotherapy, neuropathic pain, etc.

About TIKUN Europe

TIKUN Olam Europe's presence in Europe began in Greece, taking advantage of the country's potential to develop into an international center for the production of medicinal cannabis, with most of the production aimed for exportation to European countries.

With a total investment of €40m, in a 56,000m2 area in Corinth, TIKUN Europe has created the largest, for this sector, production unit in Europe, with a vertically integrated production process and an R&D department, in state-of-the-art facilities and with equipment of latest technology.

TIKUN Europe’s activity is fully aligned with the Greek legislation provisions for the cultivation and processing of medical cannabis, aiming at the creation of pharmaceutical formulations that will be produced in a GMP environment and by applying strict control standards and procedures which ensure high quality and safety.

The company utilizes TIKUN’s know-how, while having direct access to its large patient database. TIKUN's pharmaceutical formulations have effectiveness which has been verified following clinical studies and Real-World Data (RWD). 

At the beginning of 2022, TIKUN Europe will launch its CBD product line, which is produced in a certified factory in France, based on innovative formulas developed by its R&D division. The TIKUN CBD series helps with the everyday life annoyances, while at the same time benefits the entire human body. In other words, it ensures homeostasis, providing holistic, natural balance.

Media Enquiries

V+O Communication, Vaia Skandali (+30) 210.72.49.000 / (+30) 6936.567.731, Email vs@vando.gr vs@vando.gr

Αθήνα, 8/12/2021: Τις εγκαταστάσεις της TIKUN Europe, της πρώτης φαρμακευτικής εταιρίας στην Ελλάδα που δραστηριοποιείται στον τομέα της φαρμακευτικής κάνναβης, επισκέφθηκε ο...

Αθήνα, 7/10/2021: Η Tikun Europe, φαρμακευτική εταιρία παραγωγής καινοτόμων φαρμακευτικών σκευασμάτων υψηλών προδιαγραφών, με έδρα την Ελλάδα και δραστηριοποίηση σε όλη την Ευρώπη, ξεκίνησε ενεργά τη συμμετοχή της στον διάλογο για την αναβάθμιση της ποιότητας ζωής των ασθενών μέσω της παρουσίας της σε σημαντικά ιατρικά συνέδρια που διοργανώνονται από έγκριτους επιστημονικούς φορείς από την Ελλάδα και το εξωτερικό.

Ο κ. Νίκος Μπέης, Διευθύνων Σύμβουλος της Tikun Europe, επεσήμανε σχετικά: «Η Tikun Europe, η παγκόσμια εταιρεία φαρμακευτικής κάνναβης ολοκληρώνει την παραγωγική της επένδυση στην Ελλάδα, με στόχευση την λειτουργία υπερσύγχρονης φαρμακευτικής μονάδας παραγωγής σε ιδιόκτητη έκταση 56.000μ 2 στην Κόρινθο. Η στήριξη συνεδρίων που ενισχύουν την εποικοδομητική συζήτηση και ενημέρωση με έγκριτους ιατρικούς επιστήμονες, για την αναβάθμιση της ποιότητας ζωής των ασθενών, είναι σημαντικός στόχος της Εταιρείας μας. Θα συνεχίσουμε να συμμετέχουμε ενεργά με στοχευμένες ενέργειες σε συνεργασία με την ιατρική
κοινότητα και τους επαγγελματίες υγείας προς όφελος των ασθενών».

Η Tikun Europe συμμετείχε στα ακόλουθα συνέδρια:

  • Στο «21ο Πανελλήνιο Συνέδριο Περιοχικής Αναισθησίας, Θεραπείας Πόνου και Παρηγορικής Φροντίδας» που πραγματοποίησε η Ελληνική Εταιρεία Θεραπείας Πόνου & Παρηγορικής Φροντίδας ΠΑΡΗ.ΣΥ.Α., σε συνεργασία με την European Society of Regional Anaesthesia-Hellas ESRA HELLAS και την Α’ Αναισθησιολογική Κλινική του Πανεπιστημίου Αθηνών. Κατά τη διάρκεια του Συνεδρίου, πραγματοποιήθηκαν Ελεύθερες Ανακοινώσεις, Δορυφορικές Διαλέξεις, Ομιλίες, Live Demostration, Κλινικά Φροντιστήρια και συζητήσεις κατά τη διάρκεια των οποίων αναπτύχθηκαν θέματα όπως οι νέες κατευθυντήριες οδηγίες για τη διαχείριση του χρόνιου πόνου στο παιδί και στον έφηβο από τον Π.Ο.Υ., η διαχείριση χρόνιου πόνου στους επιζώντες από Covid 19 και πολλά άλλα.
  • Στο «15 ο Συμπόσιο Νευρολογίας» που διοργανώθηκε από την Ακαδημία Νευροεπιστημών, υπό την αιγίδα του Ιατρικού Συλλόγου Ιωαννίνων, με στόχο να καλύψει όλες τις τελευταίες εξελίξεις στους περισσότερους τομείς της Νευρολογίας. Κατά τη διάρκεια του Συνεδρίου, υλοποιήθηκε τετραήμερο πρόγραμμα με Δορυφορικές διαλέξεις και Συμπόσια, διαδραστικές ενότητες, πρακτικές συνεδρίες, κλινικά φροντιστήρια και συνεδρίες αφιερωμένες στις κινητικές διαταραχές, την πολλαπλή σκλήρυνση και συναφή θέματα της Νευρολογίας.
  • Στο «24ο Πανελλήνιο Συνέδριο Αναισθησιολογίας» συνεργάστηκαν δημιουργικά τα μέλη της Αναισθησιολογικής Εταιρείας, του Διοικητικού Συμβουλίου, των Επιτροπών του Συνεδρίου, αλλά και συναφών επιστημονικών εταιρειών, με την υποστήριξη της ιατροφαρμακευτικής βιομηχανίας. Στο πλαίσιο του Συνεδρίου συμμετείχαν διακεκριμένοι επιστήμονες από την Ελλάδα και το εξωτερικό και αναπτύχθηκαν θέματα όπως η αναισθησιολογία στην Ελλάδα του 2021, τα Διλήμματα κατά την περιεγχειρητική διαχείριση καρδιαγγειακού ασθενούς και πολλά άλλα.

Για την Tikun Global

Η Tikun Global είναι πρωτοπόρος εταιρεία στην Έρευνα Ανάπτυξη και παραγωγή προϊόντων
φαρμακευτικής κάνναβης παγκοσμίως. Ξεκίνησε τη δραστηριότητά της στο Ισραήλ το 2005
καθορίζοντας το Medical Cannabis Industry, με παραγωγικές μονάδες στα 5 σημεία του
πλανήτη US, Καναδά, Αυστραλία, Ασία (Ισραήλ) και Ευρώπη (Ελλάδα). Σήμερα είναι εταιρεία
ηγέτης με φαρμακευτικά σκευάσματα που έχουν βραβευθεί διεθνώς. Με πάνω από 15 χρόνια
κλινικών και εργαστηριακών μελετών και μεγάλη βάση δεδομένων με δεκάδες χιλιάδες
ασθενείς παγκοσμίως, τα καινοτόμα σκευάσματα της Tikun προσφέρουν υποστήριξη σε
σοβαρές παθήσεις όπως Καρκίνος, νόσος του Πάρκινσον, νόσος του Crohn, Αυτισμός,
Σκλήρυνση κατά πλάκας, Επιληψία κ.α.

Για την Tikun Europe

Η Tikun Europe είναι φαρμακευτική εταιρεία, η οποία αναπτύσσει, παράγει και διανέμει προϊόντα φαρμακευτικής κάνναβης, με κεντρικό στόχο τη βελτίωση της θεραπείας και της συνολικής ποιότητας ζωής των ασθενών.
Η παρουσία της Tikun στην Ευρώπη ξεκίνησε με καθετοποιημένη παραγωγική διαδικασία και
R&D, στην Ελλάδα. Η συνολική επένδυση ύψους €40εκ. αξιοποιεί τη δυναμική που έχει η
χώρα μας να εξελιχθεί σε διεθνές κέντρο παραγωγής σκευασμάτων φαρμακευτικής κάνναβης,
με το μεγαλύτερο μέρος να προορίζεται για εξαγωγές σε μεγάλες ευρωπαϊκές χώρες.
Η Tikun Europe βρίσκεται στο τελευταίο στάδιο δημιουργίας μιας state of the art φαρμακευτικής
μονάδας παραγωγής σε έκταση 56.000 m2 στην Κόρινθο, η μεγαλύτερη στην Ευρώπη, σε
υπερσύγχρονες εγκαταστάσεις και με εξοπλισμό τελευταίας τεχνολογίας.
Η παραγωγική μονάδα θα λειτουργεί με βάση αυστηρά πρότυπα ελέγχου και ποιότητας (GMP)
με στόχο τη διασφάλιση του βέλτιστου ποιοτικού αποτελέσματος, ενώ η δραστηριότητά της
είναι απολύτως ευθυγραμμισμένη με τα όσα προβλέπει η ελληνική νομοθεσία για την
καλλιέργεια και επεξεργασία κάνναβης με στόχο τη δημιουργία αξιόπιστων φαρμακευτικών
σκευασμάτων.

Media Enquiries
V+O Communication – Βάγια Σκανδάλη
Τηλ. Επικοινωνίας 210 72 49 000, 6936 567 731, Email vs@vando.gr

Αθήνα, 7/10/2021: Η Tikun Europe, φαρμακευτική εταιρία παραγωγής καινοτόμων φαρμακευτικών σκευασμάτων υψηλών προδιαγραφών, με έδρα την Ελλάδα και δραστηριοποίηση σε όλη την...